Olema Pharmaceuticals Dividends
| OLMA Stock | USD 25.36 0.35 1.40% |
As of February 8, 2026, Dividends Paid is expected to decline to about 2.5 M. The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to -717. Olema Pharmaceuticals' past performance could be the main factor of why investors trade Olema Pharmaceuticals stock today. Investors should clearly understand every aspect of the Olema Pharmaceuticals dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Olema Pharmaceuticals' dividend schedule and payout information. Olema Pharmaceuticals dividends can also provide a clue to the current valuation of Olema Pharmaceuticals.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 2.8 M | 2.5 M | |
| Dividend Paid And Capex Coverage Ratio | (754.74) | (717.00) |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Olema Pharmaceuticals must own a stock before its ex-dividend date to receive its next dividend.
Olema Pharmaceuticals Dividends Paid Over Time
Today, most investors in Olema Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Olema Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Olema Pharmaceuticals dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Olema Pharmaceuticals. Anticipated expansion of Olema directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Olema Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Olema Pharmaceuticals's market price often diverges from its book value, the accounting figure shown on Olema's balance sheet. Smart investors calculate Olema Pharmaceuticals' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Olema Pharmaceuticals' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Olema Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Olema Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Olema Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.